Zobrazeno 1 - 10
of 1 193
pro vyhledávání: '"C Nicolau"'
Autor:
Remo H.M. Furtado, Marcela G. Juliasz, Felipe Y.J. Chiu, Livia B.C. Bastos, Talia F. Dalcoquio, Felipe G. Lima, Renato Rosa, Cesar A. Caporrino, Adriadne Bertolin, Paulo R.R. Genestreti, Andre S. Ribeiro, Maria Carolina Andrade, Roberto R.C.V. Giraldez, Luciano M. Baracioli, Thomas A. Zelniker, Jose C. Nicolau
Publikováno v:
ESC Heart Failure, Vol 10, Iss 1, Pp 442-452 (2023)
Abstract Aims Left ventricular ejection fraction (LVEF) ≤ 40% is a well‐established risk factor for mortality after acute coronary syndromes (ACS). However, the long‐term prognostic impact of mildly reduced ejection fraction (EF) (LVEF 41–49%
Externí odkaz:
https://doaj.org/article/0ea3352bcc7a46c587f6b45e5a04c0c6
Autor:
Jacqueline Bosch, PhD, Paul Moayyedi, MD, PhD, Marco Alings, MD, PhD, Alvaro Avezum, Jr., MD, PhD, Shrikant I. Bangdiwala, PhD, Alan Barkun, MD, CM, MSc, Federico Cassella, MD, Aloisio Marchi da Rocha, MD, PhD, Irfan Duzen, MD, Robert Enns, MD, Nauzer Forbes, MD, MSc, Leah Hamilton, MSc, Shofiqul Islam, PhD, Mustafa Kilickap, MD, MSc, Paul Kruger, MBBS, Yan Liang, MD, Jose C. Nicolau, MD, Rafael Nunes, MD, PhD, Martin O’Donnell, MD, PhD, Gustavo Oliveira, MD, PhD, Alejandro Rey, MD, Yihong Sun, MD, Thomas Vanassche, MD, Peter Verhamme, MD, Michael Walsh, MD, PhD, Zhenyu Wang, MD, Cynthia Wu, MD, Li Zhao, MD, Jun Zhu, MD, John W. Eikelboom, MBBS
Publikováno v:
CJC Open, Vol 4, Iss 11, Pp 996-1005 (2022)
Background: Bleeding is the most common adverse event in those with cardiovascular (CV) disease receiving antithrombotic therapy, and it most commonly occurs in the gastrointestinal (GI) tract. Clinicians often dismiss bleeding as an adverse event th
Externí odkaz:
https://doaj.org/article/a3549bb6b92f4bf4a92465d7fd5f018b
Autor:
Remo Holanda de Mendonça Furtado, Paulo Rizzo Genestreti, Talia F. Dalçóquio, Luciano Moreira Baracioli, Felipe Galego Lima, André Franci, Roberto R. C. V. Giraldez, Fernando R. Menezes, Aline Gehlen Ferrari, Viviane Moreira Lima, Cesar A. C. Pereira, Carlos Alberto Kenji Nakashima, Rocio Salsoso, Lucas Colombo Godoy, José C. Nicolau
Publikováno v:
Arquivos Brasileiros de Cardiologia, Vol 116, Iss 2, Pp 285-294 (2021)
Resumo Fundamento O maior risco de se desenvolver diabetes com o uso de estatinas é um desafio para a segurança do uso dessa classe de medicamentos em longo prazo. No entanto, poucos estudos analisaram essa questão durante síndromes coronarianas
Externí odkaz:
https://doaj.org/article/09afe3c9ddf242719d983c0444062546
Autor:
José C. Nicolau
Publikováno v:
Arquivos Brasileiros de Cardiologia, Vol 119, Iss 3, Pp 458-459 (2022)
Externí odkaz:
https://doaj.org/article/50907cd5e2084809b344537975737de9
Autor:
Satoshi Yasuda, Christopher B Granger, David B Brieger, Karolina Andersson Sundell, Jiyan Chen, Tabassome Simon, Dirk Westermann, Richard Grieve, Stuart Pocock, Ruth Owen, Mauricio G Cohen, Shaun Goodman, José C Nicolau, Katarina Hedman, Carl Mellström
Publikováno v:
Open Heart, Vol 8, Iss 1 (2021)
Objective To assess associations of health-related quality of life (HRQoL) with patient profile, resource use, cardiovascular (CV) events and mortality in stable patients post-myocardial infarction (MI).Methods The global, prospective, observational
Externí odkaz:
https://doaj.org/article/ab8513e0e2e84ab490bb70fdbaa19db7
Autor:
Jose C. Nicolau, Remo H.M. Furtado, Talia F. Dalçóquio, Livia M. Lara, Marcela G. Juliasz, Aline G. Ferrari, Carlos A.K. Nakashima, Andre Franci, Cesar A.C. Pereira, Felipe G. Lima, Roberto R. Giraldez, Rocío Salsoso, Luciano M. Baracioli, Shaun Goodman
Publikováno v:
Clinics, Vol 76 (2021)
OBJECTIVES: Returning to work after an episode of acute coronary syndrome (ACS) is challenging for many patients, and has both personal and social impacts. There are limited data regarding the working status in the very long-term after ACS. METHODS:
Externí odkaz:
https://doaj.org/article/f4fd337951fb451c8b9775322545a491
Autor:
Remo H. M. Furtado, Ramkumar V. Venkateswaran, Jose C. Nicolau, Yared Gurmu, Deepak L. Bhatt, Robert F. Storey, P. Gabriel Steg, Giuglia Magnani, Shinya Goto, Mikael Dellborg, Gabriel Kamensky, Daniel Isaza, Philip Aylward, Per Johanson, Marc P. Bonaca
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 10 (2020)
Background A proposed cause of dyspnea induced by ticagrelor is an increase in adenosine blood levels. Because caffeine is an adenosine antagonist, it can potentially improve drug tolerability with regard to dyspnea. Furthermore, association between
Externí odkaz:
https://doaj.org/article/6384ab839e054078afa8fae396ae37f5
Publikováno v:
Radiología. 64:542-551
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::48e09bd61ac0bf108e9740a48886f45f
https://doi.org/10.1016/j.rx.2022.07.002
https://doi.org/10.1016/j.rx.2022.07.002
Autor:
Akshay Bagai, Faeez M. Ali, John Gregson, Karen P. Alexander, Mauricio G. Cohen, Karolina Andersson Sundell, Tabassome Simon, Dirk Westermann, Satoshi Yasuda, David Brieger, Shaun G. Goodman, Jose C. Nicolau, Christopher B. Granger, Stuart Pocock
Publikováno v:
Clinical Cardiology. 45:1277-1286
Data on the association of multimorbidity and functional impairment with cardiovascular (CV) and non-CV outcomes among older myocardial infarction (MI) patients are limited.Multimorbidity and functional impairment among older MI patients are associat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::503139dfc28c0245e2bd6231557c6cd2
https://doi.org/10.1002/clc.23915
https://doi.org/10.1002/clc.23915
Autor:
Remo H.M. Furtado, Marcela G. Juliasz, Felipe Y.J. Chiu, Livia B.C. Bastos, Talia F. Dalcoquio, Felipe G. Lima, Renato Rosa, Cesar A. Caporrino, Adriadne Bertolin, Paulo R.R. Genestreti, Andre S. Ribeiro, Maria Carolina Andrade, Roberto R.C.V. Giraldez, Luciano M. Baracioli, Thomas A. Zelniker, Jose C. Nicolau
Publikováno v:
ESC Heart Failure. 10:442-452
Left ventricular ejection fraction (LVEF) ≤ 40% is a well-established risk factor for mortality after acute coronary syndromes (ACS). However, the long-term prognostic impact of mildly reduced ejection fraction (EF) (LVEF 41-49%) after ACS remains
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bddff673e64c54351c78ef34fc5af3d1
https://doi.org/10.1002/ehf2.14201
https://doi.org/10.1002/ehf2.14201